| Efficient generation and correction of mutations in human iPS cells utilizing mRNAs of CRISPR base editors and prime editors D Sürün, A Schneider, J Mircetic, K Neumann, F Lansing, ... Genes 11 (5), 511, 2020 | 125 | 2020 |
| Nerve Growth Factor modulates LPS-induced microglial glycolysis and inflammatory responses G Fodelianaki, F Lansing, P Bhattarai, M Troullinaki, MA Zeballos, ... Experimental Cell Research 377 (1-2), 10-16, 2019 | 60 | 2019 |
| A heterodimer of evolved designer-recombinases precisely excises a human genomic DNA locus F Lansing, M Paszkowski-Rogacz, LT Schmitt, PM Schneider, ... Nucleic Acids Research 48 (1), 472-485, 2020 | 24 | 2020 |
| Correction of a Factor VIII genomic inversion with designer-recombinases F Lansing, L Mukhametzyanova, T Rojo-Romanos, K Iwasawa, M Kimura, ... Nature Communications 13 (1), 422, 2022 | 19 | 2022 |
| Pairing of single mutations yields obligate Cre-type site-specific recombinases J Hoersten, G Ruiz-Gómez, F Lansing, T Rojo-Romanos, LT Schmitt, ... Nucleic Acids Research 50 (2), 1174-1186, 2022 | 14 | 2022 |
| Precise excision of HTLV-1 provirus with a designer-recombinase T Rojo-Romanos, J Karpinski, S Millen, N Beschorner, F Simon, ... Molecular Therapy 31 (7), 2266-2285, 2023 | 10 | 2023 |
| DNA methylation–independent long-term epigenetic silencing with dCRISPR/Cas9 fusion proteins L Ding, LT Schmitt, M Brux, D Sürün, M Augsburg, F Lansing, J Mircetic, ... Life Science Alliance 5 (6), 2022 | 6 | 2022 |
| Activation of recombinases at specific DNA loci by zinc-finger domain insertions L Mukhametzyanova, LT Schmitt, J Torres-Rivera, T Rojo-Romanos, ... Nature Biotechnology, 1-11, 2024 | 5 | 2024 |
| Efficient generation and correction of mutations in human iPS cells utilizing mRNAs of CRISPR base editors and prime editors. Genes (Basel) 11: 511–519 D Sürün, A Schneider, J Mircetic, K Neumann, F Lansing, ... | 4 | 2020 |
| Designer-Rekombinasen für präzises Genome Editing J Karpinski, M Schneider, F Lansing, J Hauber, F Buchholz BIOspektrum 23, 151-154, 2017 | 3 | 2017 |
| Quantification of evolved DNA-editing enzymes at scale with DEQSeq LT Schmitt, A Schneider, J Posorski, F Lansing, M Jelicic, M Jain, S Sayed, ... Genome Biology 24 (1), 254, 2023 | 2 | 2023 |
| Engineering spacer specificity of the Cre/loxP system J Hoersten, G Ruiz-Gómez, M Paszkowski-Rogacz, G Gilioli, ... Nucleic Acids Research, gkae481, 2024 | 1 | 2024 |
| Methods and means for genetic alteration of genomes utilizing designer dna recombining enzymes F Buchholz, M Schneider, F Lansing US Patent 11,845,954, 2023 | | 2023 |
| Methods and means for genetic alteration of genomes utilizing designer dna recombining enzymes F Buchholz, M Schneider, F Lansing US Patent App. 18/046,066, 2023 | | 2023 |
| Site-specific recombinases for efficient and specific genome editing J Hoersten, F Lansing, F Buchholz US Patent App. 18/055,545, 2023 | | 2023 |
| Fusion of designer-recombinases for efficient and specific correction of a Factor VIII genomic inversion L Mukhametzyanova, F Lansing, T Rojo-Romanos, F Buchholz HUMAN GENE THERAPY 33 (23-24), A10-A11, 2022 | | 2022 |
| FUSION OF SITE-SPECIFIC RECOMBINASES FOR EFFICIENT AND SPECIFIC GENOME EDITING F BUCHHOLZ, J KARPINSKI, F LANSING, L MUKHAMETZYANOVA, ... EP Patent EP3831939A1, 2021 | | 2021 |
| Wie Designer-Rekombinasen Erbkrankheiten heilen könnten F Lansing, J Hoersten, F Buchholz BIOspektrum 27, 139-141, 2021 | | 2021 |
| Wie Designer-Rekombinasen Erbkrankheiten heilen könnten A Hämophilie | | 2021 |
| Directed evolution of site-specific recombinases for precise genome editing and rearrangement PDFJ Lansing | | 2021 |
Frank BuchholzProfessor of Medical Systems Biology, TU Dresden在 tu-dresden.de 的电子邮件经过验证
